Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway

Osteonecrosis of the femoral head (ONFH) induced by glucocorticoids (GCs) has been considered to be associated with the dysfunction of bone marrow mesenchymal stem cells (BMSCs). Studies have reported that GCs can regulate the normal differentiation of BMSCs. However, the exact mechanism of this reg...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Yugang, Xu Zechuan, Chang Shan
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
gc
Acceso en línea:https://doaj.org/article/34d315ca938743cca260c5ea021fb562
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:34d315ca938743cca260c5ea021fb562
record_format dspace
spelling oai:doaj.org-article:34d315ca938743cca260c5ea021fb5622021-12-05T14:10:41ZGlucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway2391-541210.1515/biol-2021-0102https://doaj.org/article/34d315ca938743cca260c5ea021fb5622021-10-01T00:00:00Zhttps://doi.org/10.1515/biol-2021-0102https://doaj.org/toc/2391-5412Osteonecrosis of the femoral head (ONFH) induced by glucocorticoids (GCs) has been considered to be associated with the dysfunction of bone marrow mesenchymal stem cells (BMSCs). Studies have reported that GCs can regulate the normal differentiation of BMSCs. However, the exact mechanism of this regulation remains unclear. In this study, we used methylprednisolone (MPS) to induce BMSCs, and then found that the Hippo signaling pathway was upregulated in a dose-dependent manner compared to that in the control group. In addition, the osteogenic ability of BMSCs was decreased, as evaluated by Alizarin Red S staining analysis and alkaline phosphatase activity assays, accompanied by the downregulated expression of Runx2, osteopontin, and osteocalcin. Additionally, the adipogenic capacity of BMSCs under the MPS conditions was increased, as identified by Oil Red O staining with upregulated triglyceride and PPARγ expression. Moreover, suppression by knockdown of MST1 was found to attenuate the Hippo signaling pathway and adipogenic differentiation, while enhancing osteogenic differentiation. In conclusion, our findings revealed that the Hippo signaling pathway was involved in GC-ONFH by affecting the osteogenic and adipogenic differentiation capacities of BMSCs. Our study could provide a basis for further investigation of the specific function of the Hippo pathway in ONFH.Li YugangXu ZechuanChang ShanDe Gruyterarticlebmscgconfhhippo signaling pathwayBiology (General)QH301-705.5ENOpen Life Sciences, Vol 16, Iss 1, Pp 1130-1140 (2021)
institution DOAJ
collection DOAJ
language EN
topic bmsc
gc
onfh
hippo signaling pathway
Biology (General)
QH301-705.5
spellingShingle bmsc
gc
onfh
hippo signaling pathway
Biology (General)
QH301-705.5
Li Yugang
Xu Zechuan
Chang Shan
Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
description Osteonecrosis of the femoral head (ONFH) induced by glucocorticoids (GCs) has been considered to be associated with the dysfunction of bone marrow mesenchymal stem cells (BMSCs). Studies have reported that GCs can regulate the normal differentiation of BMSCs. However, the exact mechanism of this regulation remains unclear. In this study, we used methylprednisolone (MPS) to induce BMSCs, and then found that the Hippo signaling pathway was upregulated in a dose-dependent manner compared to that in the control group. In addition, the osteogenic ability of BMSCs was decreased, as evaluated by Alizarin Red S staining analysis and alkaline phosphatase activity assays, accompanied by the downregulated expression of Runx2, osteopontin, and osteocalcin. Additionally, the adipogenic capacity of BMSCs under the MPS conditions was increased, as identified by Oil Red O staining with upregulated triglyceride and PPARγ expression. Moreover, suppression by knockdown of MST1 was found to attenuate the Hippo signaling pathway and adipogenic differentiation, while enhancing osteogenic differentiation. In conclusion, our findings revealed that the Hippo signaling pathway was involved in GC-ONFH by affecting the osteogenic and adipogenic differentiation capacities of BMSCs. Our study could provide a basis for further investigation of the specific function of the Hippo pathway in ONFH.
format article
author Li Yugang
Xu Zechuan
Chang Shan
author_facet Li Yugang
Xu Zechuan
Chang Shan
author_sort Li Yugang
title Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
title_short Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
title_full Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
title_fullStr Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
title_full_unstemmed Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
title_sort glucocorticoids induce osteonecrosis of the femoral head through the hippo signaling pathway
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/34d315ca938743cca260c5ea021fb562
work_keys_str_mv AT liyugang glucocorticoidsinduceosteonecrosisofthefemoralheadthroughthehipposignalingpathway
AT xuzechuan glucocorticoidsinduceosteonecrosisofthefemoralheadthroughthehipposignalingpathway
AT changshan glucocorticoidsinduceosteonecrosisofthefemoralheadthroughthehipposignalingpathway
_version_ 1718371833845121024